Europe Rapid Point-of-care Testing For Sickle Cell Anemia Market Size & Outlook
Related Markets
Europe rapid point-of-care testing for sickle cell anemia market highlights
- The Europe rapid point-of-care testing for sickle cell anemia market generated a revenue of USD 88.4 million in 2025.
- The market is expected to grow at a CAGR of 10.8% from 2026 to 2033.
- In terms of segment, lateral flow immunoassay was the largest revenue generating type in 2025.
- Paper-Based Rapid Diagnostics is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 88.4 million |
| Market revenue in 2033 | USD 196.7 million |
| Growth rate | 10.8% (CAGR from 2026 to 2033) |
| Largest segment | Lateral flow immunoassay |
| Fastest growing segment | Paper-Based Rapid Diagnostics |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Lateral Flow Immunoassay, Paper-Based Rapid Diagnostics, Others Type |
| Key market players worldwide | BioMedomics, Silver Lake Research, Bio-Rad Laboratories Inc, Trivitron Healthcare, Hemex Health, Sysmex Corporation, EKF Diagnostics Holdings PLC, Danaher Corp |
Other key industry trends
- In terms of revenue, Europe region accounted for 26.9% of the global rapid point-of-care testing for sickle cell anemia market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 167.3 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Rapid Point-of-Care Testing for Sickle Cell Anemia Market Scope
Rapid Point-of-Care Testing for Sickle Cell Anemia Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Hemex Health | View profile | 1-10 | Portland, Oregon, United States, North America | http://hemexhealth.com/ |
| Silver Lake Research | View profile | 11-50 | Azusa, California, United States, North America | https://www.silverlakeresearch.com/ |
| Halcyon Biomedical | View profile | - | Friendswood, Texas, United States, North America | http://halcyonbiomedical.com |
| BioMedomics | View profile | 1-10 | Morrisville, North Carolina, United States, North America | http://biomedomics.com |
| Transasia Bio Medicals | View profile | 1001-5000 | Mumbai, Maharashtra, India, Asia | http://www.transasia.co.in |
| Trivitron Healthcare | View profile | 5001-10000 | Chennai, Tamil Nadu, India, Asia | http://www.trivitron.com |
| Mylab Discovery Solutions | View profile | 11-50 | Lonavla, Maharashtra, India, Asia | https://mylabdiscoverysolutions.com/ |
| Sysmex Corp | View profile | 10448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | http://www.sysmex.co.jp |
| EKF Diagnostics Holdings PLC | View profile | 356 | 19 Stanwell Road, Penarth, Avon House, Cardiff, United Kingdom, CF64 2EZ | https://www.ekfdiagnostics.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
Europe rapid point-of-care testing for sickle cell anemia market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rapid point-of-care testing for sickle cell anemia market will help companies and investors design strategic landscapes.
Lateral flow immunoassay was the largest segment with a revenue share of 56.45% in 2025. Horizon Databook has segmented the Europe rapid point-of-care testing for sickle cell anemia market based on lateral flow immunoassay, paper-based rapid diagnostics, others type covering the revenue growth of each sub-segment from 2021 to 2033.
The European market for rapid point-of-care (POC) testing for sickle cell anemia is witnessing steady growth, driven by the increasing need for early diagnosis, especially among migrant populations from high-prevalence regions such as Sub-Saharan Africa and the Middle East.
One of the major driver for this growth is the availability of innovative and easy-to-use diagnostic tools like BioMedomics Inc.'s Sickle SCAN test. This test, a rapid immunoassay that detects hemoglobins A, S, and C, provides results in under five minutes with minimal infrastructure requiring no electricity or advanced equipment.
Its CE Mark approval has enabled the product's adoption across the European Union, reinforcing confidence in its quality and reliability. Clinical validation studies showing high sensitivity and specificity further support its use in newborn screening, genetic counseling, and population-based testing.
Reasons to subscribe to Europe rapid point-of-care testing for sickle cell anemia market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe rapid point-of-care testing for sickle cell anemia market databook
-
Our clientele includes a mix of rapid point-of-care testing for sickle cell anemia market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe rapid point-of-care testing for sickle cell anemia market , including forecasts for subscribers. This continent databook contains high-level insights into Europe rapid point-of-care testing for sickle cell anemia market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Europe rapid point-of-care testing for sickle cell anemia market size, by country, 2021-2033 (US$M)
Europe Rapid Point-of-Care Testing for Sickle Cell Anemia Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
